• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颈动脉疾病医学治疗的新策略。

New strategies in the medical treatment of carotid artery disease.

作者信息

Rajamani Kumar, Chaturvedi Seemant

机构信息

Comprehensive Stroke Program and Department of Neurology, Wayne State University, 8C-UHC, 4201 St. Antoine, Detroit, MI 48201, USA.

出版信息

Curr Treat Options Cardiovasc Med. 2008 Apr;10(2):156-63. doi: 10.1007/s11936-008-0017-x.

DOI:10.1007/s11936-008-0017-x
PMID:18325318
Abstract

Most patients with ischemic stroke or transient ischemic attack are screened for internal carotid artery stenosis. Although it is important to identify candidates for endarterectomy or stenting, the clinician must realize that most patients are not candidates for revascularization. Therefore, medical therapy remains the cornerstone of treatment. In this article, current thinking on medical therapy for carotid atherosclerosis is outlined, including aggressive use of statins, targeted blood pressure lowering, and antithrombotic therapy. Implementation of these therapies will likely reduce the need for revascularization procedures in the future.

摘要

大多数缺血性中风或短暂性脑缺血发作患者会接受颈内动脉狭窄筛查。虽然识别适合进行内膜切除术或支架置入术的患者很重要,但临床医生必须认识到,大多数患者并不适合进行血运重建。因此,药物治疗仍然是治疗的基石。本文概述了目前关于颈动脉粥样硬化药物治疗的思路,包括积极使用他汀类药物、有针对性地降低血压以及抗血栓治疗。实施这些治疗可能会减少未来血运重建手术的需求。

相似文献

1
New strategies in the medical treatment of carotid artery disease.颈动脉疾病医学治疗的新策略。
Curr Treat Options Cardiovasc Med. 2008 Apr;10(2):156-63. doi: 10.1007/s11936-008-0017-x.
2
New strategies in the medical treatment of carotid artery disease.颈动脉疾病医学治疗的新策略。
Curr Cardiol Rep. 2006 Feb;8(1):33-7. doi: 10.1007/s11886-006-0008-z.
3
Carotid Endarterectomy and Carotid Artery Stenting for Patients With Crescendo Transient Ischemic Attacks: A Systematic Review.颈动脉内膜切除术和颈动脉支架置入术治疗递增性短暂性脑缺血发作患者:系统评价。
JAMA Surg. 2019 Nov 1;154(11):1055-1063. doi: 10.1001/jamasurg.2019.2952.
4
How recent data have impacted the treatment of internal carotid artery stenosis.最近的数据如何影响颈内动脉狭窄的治疗。
J Am Coll Cardiol. 2015 Mar 24;65(11):1134-43. doi: 10.1016/j.jacc.2014.12.045.
5
Large Artery Atherosclerotic Occlusive Disease.大动脉粥样硬化性闭塞病
Continuum (Minneap Minn). 2017 Feb;23(1, Cerebrovascular Disease):133-157. doi: 10.1212/CON.0000000000000436.
6
Symptomatic Carotid Artery Stenosis: Surgery, Stenting, or Medical Therapy?有症状的颈动脉狭窄:手术、支架置入还是药物治疗?
Curr Treat Options Cardiovasc Med. 2017 Aug;19(8):62. doi: 10.1007/s11936-017-0564-0.
7
Carotid stenosis: endarterectomy or angioplasty and stenting?颈动脉狭窄:内膜切除术还是血管成形术和支架置入术?
Curr Treat Options Neurol. 2007 Nov;9(6):451-62. doi: 10.1007/s11940-007-0046-x.
8
Carotid artery stenting for recurrent carotid artery restenosis after previous ipsilateral carotid artery endarterectomy or stenting: a report from the National Cardiovascular Data Registry.颈动脉支架置入术治疗同侧颈动脉内膜切除术或支架置入术后再发颈动脉狭窄:来自国家心血管数据注册中心的报告。
JACC Cardiovasc Interv. 2014 Feb;7(2):180-186. doi: 10.1016/j.jcin.2013.11.004.
9
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.无症状性颈动脉狭窄的动脉内膜切除术。无症状性颈动脉粥样硬化研究执行委员会。
JAMA. 1995 May 10;273(18):1421-8.
10
[Diagnostic and Therapeutic Management of Carotid Artery Disease].[颈动脉疾病的诊断与治疗管理]
Praxis (Bern 1994). 2020 Jul;109(9):705-723. doi: 10.1024/1661-8157/a003475.

本文引用的文献

1
Effects of torcetrapib in patients at high risk for coronary events.托彻普对冠心病高危患者的影响。
N Engl J Med. 2007 Nov 22;357(21):2109-22. doi: 10.1056/NEJMoa0706628. Epub 2007 Nov 5.
2
High-dose atorvastatin after stroke or transient ischemic attack.中风或短暂性脑缺血发作后使用大剂量阿托伐他汀。
N Engl J Med. 2006 Aug 10;355(6):549-59. doi: 10.1056/NEJMoa061894.
3
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
依折麦布与辛伐他汀联合用药(益适纯)对比阿托伐他汀治疗高胆固醇血症患者的剂量比较研究:益适纯对比阿托伐他汀(VYVA)研究
Am Heart J. 2005 Mar;149(3):464-73. doi: 10.1016/j.ahj.2004.11.023.
4
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.阿托伐他汀强化降脂治疗稳定型冠心病患者
N Engl J Med. 2005 Apr 7;352(14):1425-35. doi: 10.1056/NEJMoa050461. Epub 2005 Mar 8.
5
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.降低胆固醇治疗效果的动脉生物学研究(ARBITER)2:一项关于缓释烟酸对接受他汀类药物治疗的二级预防患者动脉粥样硬化进展影响的双盲、安慰剂对照研究。
Circulation. 2004 Dec 7;110(23):3512-7. doi: 10.1161/01.CIR.0000148955.19792.8D. Epub 2004 Nov 10.
6
Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.他汀类药物在卒中预防和颈动脉粥样硬化中的应用:系统评价与最新荟萃分析
Stroke. 2004 Dec;35(12):2902-9. doi: 10.1161/01.STR.0000147965.52712.fa. Epub 2004 Oct 28.
7
Clinical pharmacotherapy for obesity: current drugs and those in advanced development.肥胖症的临床药物治疗:现有药物及处于研发后期的药物
Curr Drug Targets. 2004 Oct;5(7):637-46. doi: 10.2174/1389450043345191.
8
Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.缺血性卒中的抗栓和溶栓治疗:第七届美国胸科医师学会抗栓和溶栓治疗会议
Chest. 2004 Sep;126(3 Suppl):483S-512S. doi: 10.1378/chest.126.3_suppl.483S.
9
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.近期缺血性卒中或短暂性脑缺血发作高危患者中阿司匹林与氯吡格雷联用对比单用氯吡格雷的疗效(MATCH):随机、双盲、安慰剂对照试验
Lancet. 2004;364(9431):331-7. doi: 10.1016/S0140-6736(04)16721-4.
10
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.近期临床试验对美国国家胆固醇教育计划成人治疗组第三次指南的影响。
Circulation. 2004 Jul 13;110(2):227-39. doi: 10.1161/01.CIR.0000133317.49796.0E.